A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Hoffmann-La Roche
Hoffmann-La Roche
Novartis
TaiHao Medical Inc.
Novartis
Merck Sharp & Dohme LLC